ALPCO Diagnostics Prepares for Launch of Unique Immunoassays by


More Info
									ALPCO Diagnostics Prepares for Launch of Unique Immunoassays

Salem, NH, June 09, 2010 --( ALPCO Diagnostics announces the recent hiring of Leon F.
Hebert Jr., Ph.D. As ALPCO's new Diabetes and Obesity Product Manager, Dr. Hebert will be charged
with overseeing the launch of several new ELISA research tools, including: Mouse Proinsulin ELISA,
Rat Proinsulin ELISA, Mouse C-peptide ELISA, and Rat C-peptide ELISA.

Dr. Hebert holds an M.B.A. from the University of Connecticut, a J.D. from Seton Hall University School
of Law, and a Ph.D. from the University of Alabama at Birmingham. Prior to joining ALPCO, Dr. Hebert
was the Project Manager in the University of Connecticut's Office of Technology Commercialization.
Building upon his work as project manager, eight years of experience as an intellectual property attorney,
and as a researcher with an interest in type 2 diabetes, Dr. Hebert will focus on the promotion and
continued evolution of ALPCO's Diabetes & Obesity immunoassay product line.

When asked about the growth of ALPCO Diagnostics and the hiring of Dr. Hebert, Sean Conley,
President of ALPCO Diagnostics, offered the following statement: “We are very excited about Dr. Hebert
joining our team of scientists, sales, and marketing professionals. He will provide a very well rounded
approach to ALPCO's marketing efforts as we continue to develop unique, quality immunoassays to the
diabetes research community.”

About ALPCO Diagnostics
ALPCO Diagnostics develops, manufactures, and distributes research immunoassay kits. The company's
goal is to offer a diverse line of assays that appeal to its broad customer base while providing exceptional
customer service and product support.


                                                   Page 1/2
                       Press Release Distribution   Terms of Use
Contact Information:
ALPCO Diagnostics
Dan Keefe
1-603-893-8914 x241

Online Version of Press Release:
You can read the online version of this press release at:

News Image:

                                                  Page 2/2
                      Press Release Distribution   Terms of Use

To top